Tag: ownership

TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- Marrelli Capital Limited, a company that Carmelo Marrelli (the “Acquiror”), the CEO of BE Resources Inc. (the “Company”), exercises control and direction over, announces today that it has filed an early warning report in respect of its holdings in the Company. On June 11, 2025, the Acquiror acquired 769,230 common shares of the Company (the “Shares”) by way of private agreement (the “Acquisition”) with a third-party vendor.

CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health and oncology, today announced that the Company’s stockholders have approved a proposal to effect a reverse split, which was voted on at the Company’s 2025 special meeting of stockholders (the “Special Meeting”) held on May 30, 2025, and that its Board of Directors (the “Board of Directors” or “Board”) approved a 1-for-85 reverse stock split of its outstanding shares of common stock, to be effective as of 12:01 a.m. Eastern Time on June 13, 2025.

Car dealers can automate their customer retention efforts through a streamlined platform

Chicago, Illinois, June 11, 2025 (GLOBE NEWSWIRE) -- Mag Mile Capital, Inc. (OTCQB: MMCP) ("Mag Mile", or the "Company") is pleased to announce the successful closing of $9.75 million in cash out CMBS financing for the Holiday Inn at Indianapolis Airport, a premium hotel located in Indianapolis, Indiana.

TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- Apollo Technology Capital Corporation (“Apollo Capital”), which together with its affiliates and associates collectively is one of the largest shareholders of MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs”, or the “Company”), owning approximately 3% of the Company’s common stock, today issued a presentation to set forth their ambitious plan to grow your investment and help turn MediPharm around.